Daily CSR
Daily CSR

Daily CSR

Daily news about corporate social responsibility, ethics and sustainability
Tags (3) : pharmaceutical development

Syngene Extends Strategic Partnership with Bristol Myers Squibb Through 2035

Syngene Extends Strategic Partnership with Bristol Myers Squibb Through 2035
01/21/2026 | Companies
Syngene International, a global contract research, development, and manufacturing organization (CRDMO), has announced the renewal and extension of its long-term strategic partnership with Bristol Myers Squibb through 2035. The enhanced agreement significantly expands the range of integrated...
biopharmaceutical industry, Bristol Myers Squibb, cardiovascular research, clinical biomarkers, clinical trials, contract research organization, CRDMO, drug development, drug discovery, drug metabolism and pharmacokinetics, end-to-end solutions, fibrosis research, global pharma, immunology research, innovation in healthcare, integrated services, life sciences, manufacturing excellence, oncology research, patient-centric research, pharmaceutical development, pharmaceutical manufacturing, preclinical development, R&D partnership, research collaboration, strategic partnership, Syngene International, translational sciences

Breakthrough HIV Treatment: Gilead's Innovative Drug Discovery Journey

Breakthrough HIV Treatment: Gilead's Innovative Drug Discovery Journey
04/03/2025 | Companies
In 2006, Tomas Cihlar was well aware that, despite initial successes with combination therapy, HIV continued to be a global challenge with limited treatment options. At the time, he had been researching virology at Gilead for 12 years, and the first once-daily, single-tablet regimen for HIV...
antiviral therapy, biopharmaceuticals, biotechnology, breakthrough medicine, clinical trials, drug discovery, drug resistance, Gilead, global health, healthcare innovation, HIV, HIV prevention, HIV research, HIV treatment, medical innovation, medical science, pharmaceutical development, Tomas Cihlar, viral capsid, virology

Devi SenGupta Spotlight: Innovation in HIV Research

Devi SenGupta Spotlight: Innovation in HIV Research
03/17/2025 | Companies
To celebrate Women’s History Month, our Identity + Innovation spotlight highlights Devi SenGupta. Discover how her personal journey has influenced her work in advancing new treatments and supporting Gilead’s mission to find a cure for HIV. Click here to see her video.
Devi SenGupta, Gilead, healthcare advancement, HIV cure, Identity and Innovation, medical innovation, new treatments, pharmaceutical development, scientific research, women in science, Women’s History Month


Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com